RXi Pharmaceuticals (RXII +16%) pops after the firm gives a positive update on its phase 3 clinical trial of NeuVax, a cancer immunotherapy targeted for breast cancer patients not eligible for other treatment.
RXi Pharmaceuticals (RXII +16%) pops after the firm gives a positive update on its phase 3...
Recommended For You
More Trending News
About SLS Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| SLS | - | - |
| SELLAS Life Sciences Group, Inc. | ||